Methylation ofIRAK3is a novel prognostic marker in hepatocellular carcinoma
Author(s) -
Chih-Chi Kuo
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i13.3960
Subject(s) - methylation , hepatocellular carcinoma , dna methylation , cancer research , biology , methyltransferase , microbiology and biotechnology , polymerase chain reaction , cpg site , gene , gene expression , genetics
To examine the methylation levels of interleukin-1 receptor-associated kinase 3 (IRAK3) and GLOXD1 and their potential clinical applications in hepatocellular carcinoma (HCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom